» Articles » PMID: 22901211

Antiproliferative Effects of Crocin in HepG2 Cells by Telomerase Inhibition and HTERT Down-regulation

Overview
Specialty Oncology
Date 2012 Aug 21
PMID 22901211
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Crocin, the main pigment of Crocus sativus L., has been shown to have antiproliferative effects on cancer cells, but the involved mechanisms are only poor understood. This study focused on probable effect of crocin on the immortality of hepatic cancer cells. Cytotoxicity of crocin (IC50 3 mg/ml) in hepatocarcinoma HepG2 cells was determined after 48 h by neutral red uptake assay and MTT test. Immortality was investigated through quantification of relative telomerase activity with a quantitative real-time PCR-based telomerase repeat amplification protocol (qTRAP). Telomerase activity in 0.5 μg protein extract of HepG2 cells treated with 3 mg/ml crocin was reduced to about 51% as compared to untreated control cells. Two mechanisms of inhibition, i.e. interaction of crocin with telomeric quadruplex sequences and down regulation of hTERT expression, were examined using FRET analysis to measure melting temperature of a synthetic telomeric oligonucleotide in the presence of crocin and quantitative real-time RT-PCR, respectively. No significant changes were observed in the Tm telomeric oligonucleotides, while the relative expression level of the catalytic subunit of telomerase (hTERT) gene showed a 60% decrease as compared to untreated control cells. In conclusion, telomerase activity of HepG2 cells decreases after treatment with crocin, which is probably caused by down-regulation of the expression of the catalytic subunit of the enzyme.

Citing Articles

Crocin elicits potent anti-inflammatory and fibrinolytic properties post tendon injury, A new molecule for adhesion therapy.

Naimi H, Khazaei M, Sharifnia F, Hassanian S, Sayyed-Hosseinian S J Tradit Complement Med. 2025; 14(6):687-696.

PMID: 39850606 PMC: 11752112. DOI: 10.1016/j.jtcme.2024.06.001.


Mitoepigenetics pathways and natural compounds: a dual approach to combatting hepatocellular carcinoma.

Hatawsh A, Al-Haddad R, Okafor U, Diab L, Dekanoidze N, Abdulwahab A Med Oncol. 2024; 41(12):302.

PMID: 39465473 DOI: 10.1007/s12032-024-02538-8.


Potential therapeutic effects of crocin.

Pourmousavi L, Asadi R, Zehsaz F, Jadidi R Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(10):7395-7420.

PMID: 38758225 DOI: 10.1007/s00210-024-03131-6.


Anti-tumoral Immunity and Chemo-preventive Effectiveness of Herbal Extracts of Curcumin, Ginger, Clove and Amygdaline in Ehrlich Ascites Carcinoma-Challenging Mice.

Gomaa S, Nassef M, El-Naggar R, Massoud A, El-Kholy M Anticancer Agents Med Chem. 2024; 24(11):826-835.

PMID: 38623979 DOI: 10.2174/0118715206269038231203151111.


Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors.

Afzaal H, Altaf R, Ilyas U, Zaman S, Hamdani S, Khan S Front Pharmacol. 2022; 13:1048691.

PMID: 36467041 PMC: 9715757. DOI: 10.3389/fphar.2022.1048691.